Lv3
216 积分 2024-05-28 加入
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
1天前
已完结
Manufacturing CAR T Therapies: A Review of Methods, Controls, and Innovations for Scalable, Accessible Treatments
1天前
已完结
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
1天前
已完结
Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy
1天前
已完结
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy
1天前
已完结
Interventions Risk Evaluation and Management in Aseptic Manufacturing
1天前
已完结
Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma
1天前
已完结
Strategies following failure of CAR-T-cell therapy in non-Hodgkin lymphoma
2天前
已完结
Neurological complications of CAR T cell therapy for cancers
7天前
已完结
难治性弥漫性大B细胞淋巴瘤临床结局:一项来自中国的多中心真实世界研究
24天前
已完结
皖公网安备34019202002308
